Abstract View

Author(s): Khan Ramiz Viquar*1, Vaibhavi Santosh Dhangar2, Nikita Ravindra Pagare3, Koli Punam Suresh4, Pranjal Komalsing Girase5

Email(s): 1khanramiz313@gmail.com

Address:

    Department of pharmaceutics Dadasaheb Rawal Pharmacy College Dondaicha

Published In:   Volume - 5,      Issue - 6,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5602  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Withania somnifera (L.) Dunal, commonly known as Ashwagandha or Indian ginseng, is one of the most important medicinal plants used in traditional Ayurvedic medicine for more than 3000 years. It has historically been employed as a rejuvenating tonic (Rasayana) to enhance vitality, promote longevity, and improve resistance to stress. In recent years, scientific interest in Ashwagandha has increased considerably because of its broad spectrum of pharmacological activities and potential therapeutic applications. Various preclinical and clinical studies have demonstrated that Ashwagandha possesses adaptogenic, antioxidant, anti-inflammatory, antimicrobial, immunomodulatory, neuroprotective, cardio protective, antidiabetic, and reproductive health-promoting properties. These biological activities are mainly attributed to the presence of bioactive constituents such as withanolides, alkaloids, flavonoids, and other phytochemicals. Furthermore, growing evidence suggests its beneficial role in managing stress, anxiety, sleep disorders, cognitive impairment, chronic fatigue, thyroid dysfunction, and enhancement of physical performance. Despite promising outcomes, current evidence remains limited by methodological heterogeneity, variations in dosage regimens, extract standardization, study duration, and relatively small sample sizes. This review aims to provide a comprehensive overview of the Phytochemistry, pharmacological activities, therapeutic potential, and possible mechanisms of action of Withania somnifera, while critically evaluating current scientific evidence and highlighting existing limitations.

Cite this article:
Khan Ramiz Viquar, Vaibhavi Santosh Dhangar, Nikita Ravindra Pagare, Koli Punam Suresh, Pranjal Komalsing Girase. Withania somnifera (Ashwagandha): An Updated Review. IJRPAS, June 2026; 5(6): 20-35.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5602


References not available.

Related Images:



Recent Images



Methyl Red in Materials Engineering: A Systematic Review of Physicochemical, Energetic and Technological Applications Using the PRISMA Methodology
Nature to Laboratory Translation of Indole Scaffolds: Integrating Natural Product Diversity, Sustainable Synthesis, and Evidence Guided Medicinal Chemistry
Antidiuretic Hormone Deficiency and Central Diabetes Insipidus (Arginine Vasopressin Deficiency): Pathophysiology, Etiology, and Contemporary Management Strategies
Mechanistic Evaluation of Acalypha hispida in Psoriasis Using Network Pharmacology and In-vivo Experimental Models
Formulation and Evaluation of Solubility enhanced Aripiprazole Oro Dispersible Film for the improved patient compliance
LipoEdge™ Liposomal Zinc by WBCIL: From Critical Quality Attributes to Bioavailability Validation and Formulation Applications
Network Pharmacology: A Systems Biology Approach to Drug Discovery and Disease Mechanisms
Artificial Intelligence in Pharmaceutical Formulation Development: From Trial-and-Error to Data-Driven Design
Evaluation of In-Vitro Anti-Diabetic Activity And   Antioxidant Activity In Ethanolic and Hydroalcoholic Extract of leaves of Gymnema Sylvestre
Molecular Docking Approaches in Antibacterial Drug Discovery: Computational Insights into Natural Compounds

Tags